Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Review Article

SRP. 2020; 11(5): 181-184


Characteristics of Suspected Malignant Ovarian Tumor Patients Who Performed Surgery at Tertiary Referral Hospital

Brahmana Askandar Tjokroprawiro, Nila Krisna Sari, Indra Yuliati, Lies Mardiyana.

Abstract
Ovarian cancer is often called as the silent killer because the symptoms appear when the stage is advanced. This study aimed to compare the identification of malignant ovarian tumor by RMI examination and abdominal pelvic CT scan to pathology examination as gold standard. This was a cross-sectional study. The data were obtained through medical records of a suspected malignant ovarian tumor patients who performed surgery at Dr. Soetomo General Hospital, Surabaya from January 2017 to December 2018. Among 64 patients, there were 56% of patients aged 41-60 years, 53% had a normal BMI, 56% multipara, and 56% not yet menopause. The sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of CA-125 diagnostic test were 80.85%, 17.65%, 73.1%, and 25%, respectively. RMI examination had a sensitivity of 82.98% and a specificity of 41.18%. Whereas, abdominal CT scan had a sensitivity of 87.23% and a specificity of 47.1%. Examination of RMI combined with abdominal pelvic CT scan had a sensitivity and specificity of 100% and 40%, respectively. RMI examination combined with abdominal pelvic CT scan gave better results in diagnosing ovarian malignancies.

Key words: Ovarian tumors, RMI, CT scan of the abdomen



Similar Articles

Overcoming the obstacles of current photodynamic therapy in tumors using nanoparticles.
Lee D, Kwon S, Jang SY, Park E, Lee Y, Koo H
Bioactive materials. 2022; 8(): 20-34

Targeted and intracellular delivery of protein therapeutics by a boronated polymer for the treatment of bone tumors.
Yan Y, Zhou L, Sun Z, Song D, Cheng Y
Bioactive materials. 2022; 7(): 333-340

Complete ablation of tumors using synchronous chemoradiation with bimetallic theranostic nanoparticles.
Nosrati H, Attari E, Abhari F, Barsbay M, Ghaffarlou M, Mousazadeh N, Vaezi R, Kavetskyy T, Rezaeejam H, Webster TJ, Johari B, Danafar H
Bioactive materials. 2022; 7(): 74-84

ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease.
Achlaug L, Somri-Gannam L, Meisel-Sharon S, Sarfstein R, Dixit M, Yakar S, Hallak M, Laron Z, Werner H, Bruchim I
Frontiers in endocrinology. 2021; 12(): 688104

Pre treatment and post treatment positron emission tomography-computed tomography (PET-CT) to evaluate treatment response in tuberculous Tubo-Ovarian masses.
Sharma JB, Kumar R, Singh U, Kumari A, Dharmendra S, Sachani H
European journal of obstetrics, gynecology, and reproductive biology. 2021; 264(): 128-134


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.



ScopeMed Web Sites